Reach Us 44-1522-440391
Value Of Cytopathology In The Diagnosis Of Respiratory Diseases | 34205
ISSN: 2157-7099

Journal of Cytology & Histology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Value of cytopathology in the diagnosis of respiratory diseases

International Conference on Cytopathology

Qing Kay Li

The Johns Hopkins University School of Medicine, USA

ScientificTracks Abstracts: J Cytol Histol

DOI: 10.4172/2157-7099.C1.002

Although the cytology (cytopathology) was first used as a diagnostic tool in the lung disease in early 1900s, it is not until the 1960s that pulmonary cytology becomes a diagnostic discipline. Since then, tremendous improvements have been made due to the innovation of sample collection and preparation techniques. The commonly used respiratory specimens in clinical diagnosis include: sputum, bronchial brushing and washing, bronchoalveolar lavage (BAL), transbronchial fine needle aspiration (TBNA), endobronchial ultrasound-guided transbronchial fine needle aspiration (EBUS-TBNA) and transthoracic CT or ultrasound-guided fine needle aspiration (FNA). The familiarity of cyto morphological features of respiratory cells and current techniques of obtaining samples are crucial to make an accurate diagnosis. Similar to other type of non-gynecologic cytological specimens, the diagnoses of respiratory diseases are typically made based on the cyto morphological evaluation of respiratory cells. In addition, an explanation note of the diagnosis is often used in the report at our institution to report immunohistochemical and molecular results and also provide suggestions to our clinical colleagues if necessary. In this presentation, we will discuss the cyto morphological findings of both benign and malignant respiratory diseases and the differential diagnosis of lung cancers.

Qing Kay Li is an internationally recognized expert in the field of cytopathology and Co-PI in Johns Hopkins Biomarker Discovery Center. She provides diagnostic service at Johns Hopkins and Conducts Research in the field of novel biomarkers in lung and prostate cancers. Her research has been presented at many national/international meetings. She also serves as Editorial Board Member for several journals, committee member of the American Society of Cytopathology and study sections of government agents and private organizations. She has more than 70 publications and book chapters. She is also the Editor of “Diagnostic Cytopathology Board Review and Self-Assessment”.

Email: [email protected]